Total planned funding: $314,346,663
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $107,106,358 |
| Mozambique | $57,045,925 |
| Kenya | $28,718,343 |
| Botswana | $12,399,117 |
| Vietnam | $12,196,444 |
| Zambia | $10,189,449 |
| Burundi | $9,307,534 |
| Tanzania | $8,854,729 |
| South Africa | $8,730,007 |
| Democratic Republic of the Congo | $8,630,245 |
| Côte d'Ivoire | $7,129,901 |
| Papua New Guinea | $6,684,056 |
| Indonesia | $5,281,155 |
| Uganda | $4,592,442 |
| India | $4,323,000 |
| Asia Regional Program | $3,654,954 |
| Angola | $3,335,000 |
| Caribbean Region | $2,717,206 |
| Malawi | $2,610,000 |
| Rwanda | $1,713,822 |
| Central America Region | $1,646,143 |
| Haiti | $1,560,713 |
| Eswatini | $1,313,737 |
| Ethiopia | $1,154,467 |
| South Sudan | $1,051,916 |
| Cameroon | $700,000 |
| Dominican Republic | $700,000 |
| Namibia | $450,000 |
| Central Asia Region | $300,000 |
| Lesotho | $250,000 |
| Ghana | $0 |
Organizational Types
| NGO | $314,346,663 |
Program Areas
| Care | $110,548,706 |
| Treatment | $88,557,410 |
| Prevention | $69,527,673 |
| Governance and Systems | $24,095,308 |
| Testing | $21,617,566 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $82,883,949 |
| HBHC: Care: Adult Care and Support | $54,005,530 |
| HKID: Care: Orphans and Vulnerable Children | $39,202,693 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $33,706,622 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $25,483,197 |
| HVCT: Testing: HIV Testing and Counseling | $21,617,566 |
| HVTB: Care: TB/HIV | $9,339,105 |
| OHSS: Health Systems Strengthening | $9,124,820 |
| PDCS: Care: Pediatric Care and Support | $8,001,378 |
| HLAB: Laboratory Infrastructure | $7,975,791 |
| HVSI: Strategic Information | $6,994,697 |
| PDTX: Treatment: Pediatric Treatment | $5,673,461 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,548,191 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,857,032 |
| HMIN: Biomedical Prevention: Injection Safety | $452,051 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $350,000 |
| HMBL: Biomedical Prevention: Blood Safety | $130,580 |